Intratumoral Tcf1+PD-1+CD8+ T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy-Reference-Cited by-同舟云学术

Intratumoral Tcf1+PD-1+CD8+ T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy

Published:2019-01 Issue:1 Volume:50 Page:195-211.e10
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Siddiqui Imran,Schaeuble Karin,Chennupati Vijaykumar,Fuertes Marraco Silvia A.,Calderon-Copete Sandra,Pais Ferreira Daniela,Carmona Santiago J.,Scarpellino Leonardo,Gfeller David,Pradervand Sylvain,Luther Sanjiv A.,Speiser Daniel E.,Held Werner

Funder

Swiss National Science Foundation

SNSF

Swiss Cancer League

SCL

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference56 articles.

1. HTSeq--a Python framework to work with high-throughput sequencing data;Anders;Bioinformatics,2015

2. Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients;Baitsch;J. Clin. Invest.,2011

3. Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity;Broz;Cancer Cell,2014

4. High-dimensional single cell analysis identifies stem-like cytotoxic CD8+ T cells infiltrating human tumors;Brummelman;J. Exp. Med.,2018

5. Elements of cancer immunity and the cancer-immune set point;Chen;Nature,2017

Cited by 1045 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Powerful microscopy technologies decode spatially organized cellular networks that drive response to immunotherapy in humans;Current Opinion in Immunology;2024-12

2. Advances in Vaccines for Melanoma;Hematology/Oncology Clinics of North America;2024-10

3. Expansion of tumor-reactive CD8 ⁺ T cell clonotypes occurs in the spleen in response to immune checkpoint blockade;Science Immunology;2024-09-13

4. Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes;Molecular Cancer;2024-09-09

5. Cell Identity and Spatial Distribution of PD‐1/PD‐L1 Blockade Responders;Advanced Science;2024-09-09